- £218.75bn
- £236.77bn
- $54.07bn
- 78
- 14
- 98
- 73
REG - AstraZeneca PLC - Publication of a Prospectus
AnnouncementREG - AstraZeneca PLC - Update: lanabecestat Phase III Alzheimer's trials
AnnouncementREG - AstraZeneca PLC - EU APPROVES TAGRISSO FOR 1ST-LINE NSCLC
AnnouncementREG - AstraZeneca PLC - Director Declaration
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Director Declaration
AnnouncementREG - AstraZeneca PLC - Update on TERRANOVA PIII trial for Fasenra in COPD
AnnouncementREG - AstraZeneca PLC - AZ's Imfinzi: significant OS in Stage III nsclc
AnnouncementREG - AstraZeneca PLC - AZ regulatory submission in Japan for Forxiga
AnnouncementREG - AstraZeneca PLC - US FDA approves Lokelma for adult hyperkalaemia
AnnouncementREG - AstraZeneca PLC - Result of AGM
AnnouncementREG - AstraZeneca PLC - AZN: Q1 2018 Results
AnnouncementREG - AstraZeneca PLC - AstraZeneca update on Fasenra PIII trial in COPD
AnnouncementREG - AstraZeneca PLC - EMA approves Lynparza: maintenance ovarian cancer
AnnouncementREG - AstraZeneca PLC - AZ and Luye Pharma enter agreement for Seroquel
AnnouncementREG - AstraZeneca PLC - Director Declaration
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - Circassia Pharma Plc AstraZeneca PLC - Issue of Equity - AstraZeneca
Announcement